Not Tagged
Sana Biotechnology
[]
sana biotechnology highlights preclinical hypoimmune data for its allogeneic car t platform and advancements with its in vivo fusogen platform with four presentations at the 2023 aacr annual meeting - cd19-directed car t cells persist and remain functio... 
CEO Of Digital Media Online